Content
07/25/2024 Tel Aviv Israel
Scopio Labs completed $42 million Series D Round funding. Investors include Fortissimo Capital.
#MedTech  
About
Scopio Labs is transforming cell morphology analysis, offering fully digital applications, platforms, and diagnostic support that enhance clinical workflows. By assisting lab experts with fast, early, and accurate detection and diagnosis of disease, Scopio expedites patients' access to life-saving treatments.
Startup
Scopio Labs
https://www.scopiolabs.com Claim Profile
Location:
Tel Aviv Israel
Sector:
MedTech
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.